Last reviewed · How we verify

Clonidine Pill

Weill Medical College of Cornell University · FDA-approved active Small molecule

Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity by stimulating alpha-2 receptors in the brain and periphery.

Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic nervous system activity by stimulating alpha-2 receptors in the brain and periphery. Used for Hypertension, Attention-deficit/hyperactivity disorder (ADHD), Opioid withdrawal.

At a glance

Generic nameClonidine Pill
Also known asOn-Drug, Clonidine
SponsorWeill Medical College of Cornell University
Drug classAlpha-2 adrenergic agonist
TargetAlpha-2 adrenergic receptor
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Clonidine binds to alpha-2 adrenergic receptors in the central nervous system, particularly in the locus coeruleus, which decreases the release of norepinephrine and reduces overall sympathetic outflow. This leads to decreased heart rate, blood pressure, and peripheral vascular resistance. The drug also has peripheral alpha-2 agonist effects that contribute to its antihypertensive action.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results